Immunic Hosts Progressive Multiple Sclerosis R&D Day

PUBT · 3d ago
Immunic Hosts Progressive Multiple Sclerosis R&D Day
  • Immunic will host a virtual progressive multiple sclerosis R&D Day on November 5, 2026, at 12:30 p.m. ET.
  • Discussions will focus on vidofludimus calcium’s potential in progressive MS, including plans to initiate a Phase 3 trial later in 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunic Inc. published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2424564_en) on October 29, 2026, and is solely responsible for the information contained therein.